Arkolith/Insider Trading/BTTX/Form 4

Parker Geoffrey M.

DirectorBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Nov 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2021Grant(A)33K——33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 28, 2021Grant(A)28K—$028K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-042253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML